BlueWillow Biologics
Hugo Acosta, CQT, has extensive experience in the life sciences sector, currently serving as Senior Scientist/Lab Manager at BlueWillow Biologics, Inc. since February 2018. Prior to this role, Hugo Acosta worked at NanoBio Corporation from May 2014 to January 2018 as a Sr. Research Associate and Research Associate. Hugo Acosta's career began at the University of Michigan, where positions included Research Lab Specialist and Research Lab Technician from June 2004 to May 2014. Hugo Acosta holds a Bachelor's Degree in Biology and Psychology from the University of Michigan-Dearborn, earned between 2000 and 2004.
This person is not in the org chart
BlueWillow Biologics
BlueWillow Biologics® is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. The platform employs novel oil-in-water nano-droplets for products administered to the skin and nose. The company was founded as a spin-off from the University of Michigan, and was initially focused on developing nano-scale dermatology applications. Based on promising research generated under several Gates Foundation, NIH and DOD contracts, BlueWillow’s technology has been advanced significantly in recent years yielding several therapies in development.